# Avicena North America Inc. — Form D

Avicena North America Inc. of ALEXANDRIA, VA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-24. The offering totals $44.4M, of which $44.4M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2022-03-24
- Form: D
- Accession: 0001909215-22-000001
- Industry: Other Health Care
- Exemptions: 06b, 4a5
- Total offering: $44.4M
- Amount sold: $44.4M
- Minimum investment: $1K
- Investors: 3
- Date of first sale: 2022-03-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438794

## Issuer

- Name: Avicena North America Inc.
- CIK: 0001909215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 209 N PAYNE ST, ALEXANDRIA, VA, 22314
- Phone: 706-372-2124

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Anthony Fitzgerald | Director | West Perth, C3 |
| William Jackson | Director | Atlanta, GA |
| Paul Watt | Director | West Perth, C3 |
| William Jackson | Executive Officer | Atlanta, GA |

## More

- [CIK 1909215 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1909215&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001909215-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.